Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.96% | $3.25B | €402.31B | 42.94% | 76 Outperform | |
| Roche Holding AG | 1.19% | $1.98B | CHF260.02B | 43.23% | 73 Outperform | |
| AstraZeneca | 1.16% | $1.93B | £207.51B | 31.59% | 80 Outperform | |
| HSBC Holdings | 1.15% | $1.91B | £207.34B | 56.88% | 80 Outperform | |
| Novartis AG | 1.08% | $1.78B | CHF206.50B | 23.38% | 80 Outperform | |
| SAP SE | 1.03% | $1.71B | €240.66B | -16.07% | 66 Neutral | |
| Nestlé SA | 1.02% | $1.69B | CHF193.19B | 16.97% | 71 Outperform | |
| Siemens | 0.89% | $1.48B | €190.85B | 27.21% | 74 Outperform | |
| Shell (UK) | 0.89% | $1.47B | £155.86B | 4.97% | 73 Outperform | |
| Toyota Motor | 0.85% | $1.41B | ¥44.30T | 13.88% | 80 Outperform |